4 suspended. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Suspended 4 |
| Phase 1 | 1 | Suspended 1 |
Follow Prostate Cancer: new trials by email Literature Review of Prostate Cancer trials Research Report on Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer Abivertinib, Abiraterone - Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Suspended | Sorrento Therapeutics, Inc. | 100 | 2025-09-01 | 2024-03-18 |
| Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical N-111, Placebo - Prostate Cancer | Phase 1 / Phase 2 | Suspended | Optimal Health Research | 100 | 2024-08-15 | 2025-03-11 |
| Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer Hyperpolarized C13, Magnetic Resonance Imaging (MRI) - Prostate Cancer, Advanced Prostate Carcinoma | Phase 2 | Suspended | Ivan de Kouchkovsky, MD | 75 | 2020-07-16 | 2026-06-23 |
| Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients docetaxel, laparoscopic radical prostatectomy - Prostate Cancer | Phase 2 | Suspended | Gustave Roussy, Cancer Campus, Grand Paris | 37 | 2004-10-01 | 2006-09-11 |
Genital Diseases (4) · Genital Diseases, Male (4) · Genital Neoplasms, Male (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Prostatic Diseases (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4)
Docetaxel (1) · Magnetic Resonance Spectroscopy (1) · abiraterone (1) · abivertinib (1)
Gustave Roussy, Cancer Campus, Grand Paris (1) · Ivan de Kouchkovsky, MD (1) · Optimal Health Research (1) · Sorrento Therapeutics, Inc. (1)
United States (3) · France (1)
Alan Jeppsen, MD (1) · Ivan de Kouchkovsky, MD (1) · Karim Fizazi, Dr (1) · Mike Royal, MD (1)
R01CA215694 (1), U01EB026412 (1)